| Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 60.05 mm | 60.05 mm | 60.05 mm | 60.05 mm | 60.05 mm | 60.05 mm |
| Cash burn (monthly) | 38.83 mm | 174.67 k | 48.53 mm | 42.93 mm | 43.82 mm | 30.46 mm |
| Cash used (since last report) | 108.76 mm | 489.27 k | 135.93 mm | 120.26 mm | 122.75 mm | 85.33 mm |
| Cash remaining | -48.71 mm | 59.56 mm | -75.88 mm | -60.21 mm | -62.70 mm | -25.27 mm |
| Runway (months of cash) | -1.3 | 341.0 | -1.6 | -1.4 | -1.4 | -0.8 |
| 13F holders | Current |
|---|---|
| Total holders | 228 |
| Opened positions | 43 |
| Closed positions | 36 |
| Increased positions | 84 |
| Reduced positions | 61 |
| 13F shares | Current |
|---|---|
| Total value | 2.48 tn |
| Total shares | 154.15 mm |
| Total puts | 36.80 k |
| Total calls | 63.10 k |
| Total put/call ratio | 0.6 |
| Largest owners | Shares | Value |
|---|---|---|
| BlackRock | 13.92 mm | $283.69 bn |
| Baillie Gifford & Co | 12.31 mm | $250.96 bn |
| Vanguard | 12.02 mm | $244.99 bn |
| ARCH Venture Fund VIII | 10.67 mm | $893.61 mm |
| Wellington Management | 9.85 mm | $200.70 bn |
| FMR | 8.02 mm | $163.44 bn |
| BIIB Biogen | 7.16 mm | $211.80 mm |
| Douglas K Bratton | 5.66 mm | $94.59 mm |
| Capital Research Global Investors | 5.48 mm | $111.63 bn |
| Temasek | 5.36 mm | $109.15 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Jun 25 | Tessier-Lavigne Marc | Common Stock | Grant | Acquire A | No | No | 0 | 6,037 | 0.00 | 1,886,576 |
| 3 Jun 25 | Tessier-Lavigne Marc | Stock Option Common Stock | Grant | Acquire A | No | No | 13.93 | 18,111 | 252.29 k | 18,111 |
| 3 Jun 25 | Nancy Thornberry | Common Stock | Grant | Acquire A | No | No | 0 | 6,037 | 0.00 | 24,717 |
| 3 Jun 25 | Nancy Thornberry | Stock Option Common Stock | Grant | Acquire A | No | No | 13.93 | 18,111 | 252.29 k | 18,111 |
| 3 Jun 25 | Schenkein David P | Common Stock | Grant | Acquire A | No | No | 0 | 6,037 | 0.00 | 15,257 |
| 3 Jun 25 | Schenkein David P | Stock Option Common Stock | Grant | Acquire A | No | No | 13.93 | 18,111 | 252.29 k | 18,111 |
| 3 Jun 25 | Krognes Steve E. | Common Stock | Grant | Acquire A | No | No | 0 | 6,037 | 0.00 | 31,794 |
| 3 Jun 25 | Krognes Steve E. | Stock Option Common Stock | Grant | Acquire A | No | No | 13.93 | 18,111 | 252.29 k | 18,111 |
| 3 Jun 25 | Peter S Klein | Common Stock | Grant | Acquire A | No | No | 0 | 6,037 | 0.00 | 27,533 |
| 3 Jun 25 | Peter S Klein | Stock Option Common Stock | Grant | Acquire A | No | No | 13.93 | 18,111 | 252.29 k | 18,111 |
